发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| CHINA MAINLAND | 78 |
| USA | 40 |
| GERMANY (FED REP GER) | 9 |
| Sweden | 6 |
| Australia | 5 |
| France | 5 |
| Japan | 5 |
| Canada | 4 |
| England | 4 |
| Belgium | 2 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| ZHENGZHOU UNIVERSITY | 12 |
| NANJING MEDICAL UNIVERSITY | 8 |
| NEW YORK MEDICAL COLLEGE | 8 |
| ZHEJIANG UNIVERSITY | 8 |
| FUDAN UNIVERSITY | 6 |
| CHINESE ACADEMY OF MEDICAL SCIENCES - PEKING U... | 5 |
| JINAN UNIVERSITY | 4 |
| LUND UNIVERSITY | 4 |
| PENNSYLVANIA COMMONWEALTH SYSTEM OF HIGHER EDU... | 4 |
| SHANDONG UNIVERSITY | 4 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Epigenetic regulation of cancer progression by EZH2: fro... | 48 |
| Exosomes from mesenchymal stem/stromal cells: a new ther... | 43 |
| Biomarkers of cytokine release syndrome and neurotoxicit... | 37 |
| Isocitrate dehydrogenase inhibitors in acute myeloid leu... | 17 |
| Novel insights into MSC-EVs therapy for immune diseases | 14 |
| Gilteritinib: a novel FLT3 inhibitor for acute myeloid l... | 14 |
| Epigenetic heterogeneity in cancer | 13 |
| Mesothelin as a biomarker for targeted therapy | 12 |
| Comprehensive analysis of peroxiredoxins expression prof... | 10 |
| Molecular landscape and targeted therapy of acute myeloi... | 10 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| J HEMATOL ONCOL | 25 |
| BIOMARK RES | 24 |
| CANCERS | 19 |
| INT J MOL SCI | 16 |
| SCI REP-UK | 14 |
| EXP HEMATOL ONCOL | 11 |
| FRONT IMMUNOL | 11 |
| ONCOTARGETS THER | 10 |
| CELLS-BASEL | 8 |
| FRONT ONCOL | 8 |